Metraipolis › archive › dc_ef40e0b86d2b
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions — Europe PMC PMID:41281703
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41281703
- DOI
- 10.1177/17562864251374903
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T08:42:05.555Z
- SHA-256 of the archived text
afee29050adfa41197192d5d56bcf8b55061e01d80686be76c4e688e668cf037- Stable URL of this page
https://metraipolis.com/documento/dc_ef40e0b86d2b
How to cite
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions — Europe PMC PMID:41281703 — Europe PMC (en), https://europepmc.org/article/MED/41281703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef40e0b86d2b (Metraipolis archive dc_ef40e0b86d2b, sha256 afee29050adfa41197192d5d56bcf8b55061e01d80686be76c4e688e668cf037)
BibTeX
@misc{dcef40e0b86d2b,
title = {Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions — Europe PMC PMID:41281703},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41281703},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef40e0b86d2b; sha256 afee29050adfa41197192d5d56bcf8b55061e01d80686be76c4e688e668cf037},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41281703. Agents can read the archived copy with the MCP tool read_document.